Balkan Journal of Medical Genetics

ANALYSIS OF THE MITOCHONDRIAL 4977 bp DELETION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
Guo ZS1,§,*, Jin CL2,§, Yao ZJ1, Wang YM1, Xu BT3,* §The first two authors contributed equally for this study.
*Corresponding Author: Dr. Zhen-Shan Guo or Dr. Bo-Tao Xu, Zhuji People’s Hospital, Jianmin Road 9, Taozhu Street, Shaoxing, 311800, People’s Republic of China. Tel./Fax: +86-0575-81782103. E-mail: Dr. Zhen-Shan Guo: guozs001@126.com; Dr. Bo-Tao Xu: 375640722@qq.com
page: 81

MATERIALS AND METHODS

Clinical Samples and DNA Extraction. Blood and tissues of 105 patients with HCC were collected at Zhuji People’s Hospital, Shaoxing, People’s Republic of China (PRC). The lesion and the nearby normal tissue from the subjects were confirmed histologically by a pathologist. Moreover, a total of 69 peripheral blood samples from age-matched donors who had a cancer free history and had no other known diseases that could be associated with mt defects were also recruited at the physical examination center in our hospital. Informed consent from all participants in this study was obtained under protocols approved by Zhuji People’s Hospital. Tumor tissues on slides were extracted separately under a microscope, and genomic DNA was isolated as previously described [8]. Briefly, total DNA was extracted from formalin-fixed, paraffinembedded tissues using the E.Z.N.A.® FFPE DNA isolation kit (Omega BioTek Inc, Norcross, GA, USA; http:// omegabiotek.com/store/product/e-z-n-a-tissue-dna-kit/), according to the manufacturer’s protocol. The isolated DNA was eluted in 100 µL Tris-EDTA buffer included in the E.Z.N.A.® FFPE DNA kit and stored at –20 °C until required. Moreover, the genomic DNA from peripheral blood leukocytes of the patients and the controls were also extracted, using the universal Genomic DNA Extraction kit version 3.0 (Takara Bio Inc, Dalian, Japan). The quality of the isolated DNA was assessed by NanoDrop spectrophotometer (NanoDrop Technologies, Thermo Fisher Scientific Inc, Waltham, MA, USA). The optical density values of all samples ranged from 1.8 to 2.0. Detection of the Mitochondrial DNA 4977 bp Deletion. To screen the 4977 bp deletion in mtDNA, nestedpolymerase chain reaction (nested-PCR) analysis was performed; we used the DNA samples extracted from the tissues as templates. In brief, two pairs of nested primers for detection of the 4977 bp deletion were as follows: 1F: 5’-AAC CAC AGT TTC ATG CCC ATC-3’; 1R: 5’-TGT TAG TAA GGG TGG GGA AGC-3’; 2F: 5’-ACC CTA TTG CAC CCC CTC TAC-3’; 2R: 5’-CTT GTC AGG GAG GTA GCG ATG-3’. The PCR condition was as follows: pre denaturation at 94 °C for 5 min.; then 30 cycles at 94 °C for 10 seconds, 58 °C for 45 seconds and 72 °C for 50 seconds; and a final extension at 72 °C for 10 min. The PCR products were then electrophoresed on a 2.0% agarose gel. The presence of the 4977 bp deletion was indicated by the appearance of a 358 bp band that was verified by sequencing analysis [9]. The wild-type mtDNA as the template would not yield any PCR products under such conditions because of the large flanking region (>5 kb). Analysis of Mitochondrial DNA Copy Number. The DNA extracted from blood samples was used to determine its mtDNA copy number. The mtDNA copy number was measured with a real-time-PCR using an Applied Biosystems 7900 Sequence Detection System (Applied Biosystems, Foster City, CA, USA). One primer pair specific for the mtDNA (ND1) and another primer pair specific for the nuclear DNA (18s) were designed for relative quantification of the mtDNA copy number. The primer sequences for the mt ND1 gene were: forward primer (ND1-F): 5’-CCC TAA AAC CCG CCA CAT CT-3’; reverse primer (ND1-R): 5’GAG CGA TGG TGA GAG CTA AGG T-3’. The primer pair used for the amplification of the nuclear gene 18s was as follows: forward primer (18s-F): 5’-TAG AGG GAC AAG TGG CGT TC-3’; reverse primer (18s-R): 5’-CGC TGA GCC AGT CAG TGT-3’. The 14 µL PCR mixture contained 1X SYBR Green mixture, 215 nM 18s-R primer, 215 nM 18s-F primer, and 0.4 ng of genomic DNA for ND1 and 18s. The thermal cycling conditions were 95 °C for 10 min., followed by 40 cycles of 95 °C for 15 seconds, and 60 °C for 1 min. for ND1 and 62 °C for 1 min. for 18s. Standard curves made by serial dilution of a reference DNA sample was used to determine the ratio of mtDNA copy number to the amount of nuclear DNA that was proportional to the mtDNA copy number in each cell. The efficiency of all quantitative PCR ranged from 99.0 to 110.0%. The R2 for all standard curves was ≥0.99. Standard deviations (SD) for the cycle of threshold (Ct) duplicates was ≤0.25. All samples were assayed in duplicate on a 96-well plate. Determining the Reactive Oxygen Species Levels in Plasma. The blood samples were immediately placed into sterile EDTA test tubes and centrifuged at 1500 g for 20 min. at 4 °C to collect plasma. Plasma was stored at –70 °C until assayed. The concentration of ROS was analyzed by enzyme-linked immunosorbent serologic assay (ELISA) using commercial kits (Nova Biomedical, Boston, MA, USA), in accordance with the manufacturer’s instructions. Statistical Analysis. All statistical analyses were performed using the Statistical Package for the Social Sciences (SPSS) software version 17.0 (SPSS Inc, Chicago, IL, USA). The mtDNA relative content and common deletion level were analyzed by the independence-samples t-test. A p value of <0.05 was considered statistically significant.

Number 27 VOL. 27 (2), 2024	Number 27 VOL. 27 (1), 2024
Number 26 Number 26 VOL. 26(2), 2023 All in one	Number 26 VOL. 26(2), 2023
Number 26 VOL. 26, 2023 Supplement	Number 26 VOL. 26(1), 2023
Number 25 VOL. 25(2), 2022	Number 25 VOL. 25 (1), 2022
Number 24 VOL. 24(2), 2021	Number 24 VOL. 24(1), 2021
Number 23 VOL. 23(2), 2020	Number 22 VOL. 22(2), 2019
Number 22 VOL. 22(1), 2019	Number 22 VOL. 22, 2019 Supplement
Number 21 VOL. 21(2), 2018	Number 21 VOL. 21 (1), 2018
Number 21 VOL. 21, 2018 Supplement	Number 20 VOL. 20 (2), 2017
Number 20 VOL. 20 (1), 2017	Number 19 VOL. 19 (2), 2016
Number 19 VOL. 19 (1), 2016	Number 18 VOL. 18 (2), 2015
Number 18 VOL. 18 (1), 2015	Number 17 VOL. 17 (2), 2014
Number 17 VOL. 17 (1), 2014	Number 16 VOL. 16 (2), 2013
Number 16 VOL. 16 (1), 2013	Number 15 VOL. 15 (2), 2012
Number 15 VOL. 15, 2012 Supplement	Number 15 Vol. 15 (1), 2012
Number 14 14 - Vol. 14 (2), 2011	Number 14 The 9th Balkan Congress of Medical Genetics
Number 14 14 - Vol. 14 (1), 2011	Number 13 Vol. 13 (2), 2010
Number 13 Vol.13 (1), 2010	Number 12 Vol.12 (2), 2009
Number 12 Vol.12 (1), 2009	Number 11 Vol.11 (2),2008
Number 11 Vol.11 (1),2008	Number 10 Vol.10 (2), 2007
Number 10 10 (1),2007	Number 9 1&2, 2006
Number 9 3&4, 2006	Number 8 1&2, 2005
Number 8 3&4, 2004	Number 7 1&2, 2004
Number 6 3&4, 2003	Number 6 1&2, 2003
Number 5 3&4, 2002	Number 5 1&2, 2002
Number 4 Vol.3 (4), 2000	Number 4 Vol.2 (4), 1999
Number 4 Vol.1 (4), 1998	Number 4 3&4, 2001
Number 4 1&2, 2001	Number 3 Vol.3 (3), 2000
Number 3 Vol.2 (3), 1999	Number 3 Vol.1 (3), 1998
Number 2 Vol.3(2), 2000	Number 2 Vol.1 (2), 1998
Number 2 Vol.2 (2), 1999	Number 1 Vol.3 (1), 2000
Number 1 Vol.2 (1), 1999	Number 1 Vol.1 (1), 1998

About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact